Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia

Aim: To increase the effectiveness of anticancer vaccine delivery and activity via its immobilization on reconstructed chromatin (RC). Materials and Methods: The hybrid mice of CDF-1 line with transplanted P-388 leukemia were used. Reconstructed chromatin was obtained from the thymus of inbred rats....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental Oncology
Datum:2013
Hauptverfasser: Janisch, Yu.V., Artamonova, A.B., Shlyakhovenko, V.A.
Format: Artikel
Sprache:English
Veröffentlicht: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2013
Schlagworte:
Online Zugang:https://nasplib.isofts.kiev.ua/handle/123456789/145248
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia / Yu.V. Janisch, A.B. Artamonova, V.A. Shlyakhovenko // Experimental Oncology. — 2013. — Т. 35, № 3. — С. 198-201. — Бібліогр.: 10 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id nasplib_isofts_kiev_ua-123456789-145248
record_format dspace
spelling Janisch, Yu.V.
Artamonova, A.B.
Shlyakhovenko, V.A.
2019-01-19T21:09:53Z
2019-01-19T21:09:53Z
2013
Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia / Yu.V. Janisch, A.B. Artamonova, V.A. Shlyakhovenko // Experimental Oncology. — 2013. — Т. 35, № 3. — С. 198-201. — Бібліогр.: 10 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/145248
Aim: To increase the effectiveness of anticancer vaccine delivery and activity via its immobilization on reconstructed chromatin (RC). Materials and Methods: The hybrid mice of CDF-1 line with transplanted P-388 leukemia were used. Reconstructed chromatin was obtained from the thymus of inbred rats. Glycopeptide cancer vaccine prepared from P-388 leukemia cells, was immobilized of RC. ζ-potential of thymocytes from tumor-bearing mice was calculated from Smoluchowski equation. Results: The data have demonstrated the principal possibility of using the fragments of reconstructed chromatin of heterologous origin as a carrier of glycopeptide cancer vaccine prepared from the cells of P-388 leukemia. Preventive immunization with the correspondingly immobilized vaccine normalized ζ-potential of thymocytes in animals with transplanted P‑388 leukemia. Conclusions: The use of immobilization of glycopeptide cancer vaccine on reconstructed chromatin improves anticancer activity of the vaccination.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Original contributions
Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
Article
published earlier
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
title Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
spellingShingle Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
Janisch, Yu.V.
Artamonova, A.B.
Shlyakhovenko, V.A.
Original contributions
title_short Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
title_full Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
title_fullStr Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
title_full_unstemmed Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
title_sort glycopeptide vaccine on dna-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
author Janisch, Yu.V.
Artamonova, A.B.
Shlyakhovenko, V.A.
author_facet Janisch, Yu.V.
Artamonova, A.B.
Shlyakhovenko, V.A.
topic Original contributions
topic_facet Original contributions
publishDate 2013
language English
container_title Experimental Oncology
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
format Article
description Aim: To increase the effectiveness of anticancer vaccine delivery and activity via its immobilization on reconstructed chromatin (RC). Materials and Methods: The hybrid mice of CDF-1 line with transplanted P-388 leukemia were used. Reconstructed chromatin was obtained from the thymus of inbred rats. Glycopeptide cancer vaccine prepared from P-388 leukemia cells, was immobilized of RC. ζ-potential of thymocytes from tumor-bearing mice was calculated from Smoluchowski equation. Results: The data have demonstrated the principal possibility of using the fragments of reconstructed chromatin of heterologous origin as a carrier of glycopeptide cancer vaccine prepared from the cells of P-388 leukemia. Preventive immunization with the correspondingly immobilized vaccine normalized ζ-potential of thymocytes in animals with transplanted P‑388 leukemia. Conclusions: The use of immobilization of glycopeptide cancer vaccine on reconstructed chromatin improves anticancer activity of the vaccination.
issn 1812-9269
url https://nasplib.isofts.kiev.ua/handle/123456789/145248
citation_txt Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia / Yu.V. Janisch, A.B. Artamonova, V.A. Shlyakhovenko // Experimental Oncology. — 2013. — Т. 35, № 3. — С. 198-201. — Бібліогр.: 10 назв. — англ.
work_keys_str_mv AT janischyuv glycopeptidevaccineondnahistonecarrieranditsimpactonζpotentialofeffectorcellsduringexperimentaltreatmentoflymphoblasticleukemia
AT artamonovaab glycopeptidevaccineondnahistonecarrieranditsimpactonζpotentialofeffectorcellsduringexperimentaltreatmentoflymphoblasticleukemia
AT shlyakhovenkova glycopeptidevaccineondnahistonecarrieranditsimpactonζpotentialofeffectorcellsduringexperimentaltreatmentoflymphoblasticleukemia
first_indexed 2025-12-07T20:56:55Z
last_indexed 2025-12-07T20:56:55Z
_version_ 1850884505069420544